AI assistant
Sending…
Oklo Inc. — Director's Dealing 2025
Apr 2, 2025
30350_dirs_2025-04-02_9b450c08-8b3e-4427-9840-370035912456.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Oklo Inc. (OKLO)
CIK: 0001849056
Period of Report: 2025-03-13
Reporting Person: Cochran Caroline (Director, Co-Founder, COO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-13 | Class A Common Stock | M | 39326 | — | Acquired | 10522411 | Direct |
| 2025-03-13 | Class A Common Stock | F | 20303 | $23.95 | Disposed | 10502108 | Direct |
| 2025-03-13 | Class A Common Stock | M | 56180 | — | Acquired | 10834106 | Indirect |
| 2025-03-13 | Class A Common Stock | F | 29008 | $23.95 | Disposed | 10805098 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-13 | Restricted Stock Units | $ | M | 39326 | Disposed | Class A Common Stock (39326) | Direct | |
| 2025-03-13 | Restricted Stock Units | $ | M | 56180 | Disposed | Class A Common Stock (56180) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 2000000 | Indirect |
| Class A Common Stock | 2000000 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 13, 2025, 56,180 and 39,326 restricted stock units were released to Mr. DeWitte and Ms. Cochran, respectively.
F2: Represents securities held by the Reporting Person's spouse.
F3: The restricted stock units vest in 12 substantially equal quarterly installments beginning on August 9, 2024.
More from Oklo Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
Apr 21
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25